In response to the COVID-19 pandemic, neurologists around the world are sharing information regarding the use of immunosuppressive disease-modifying therapies (DMT) for patients with MS. The Italian Society of Neurologists issued its recommendations (in Italian) last week which were then translated and shared via the UK’s BartsMS blog. Professor Gavin Giovannoni, from Barts and The ...
COVID-19: advice to delay lymphodepleting drugs in MS
By Mardi Chapman
18 Mar 2020